Australian laws and regulations limit the amount of information we can provide to the general public via our website. Our Consumer Medicine Information (CMI) leaflets are intended for patients who have been prescribed our products. They provide information on the safe and effective use of the prescription medicine. Our Product Information (PI) sheets are intended for healthcare professionals. They provide a summary of the essential scientific information for the safe and effective use of a prescription medicine.



ALOXI® injection

Eligard® Injection

Bi Eligard® Composite Pack

bicalutamide & leuprorelin acetate

FOLOTYN® injection

® AKYNZEO and ALOXI are registered trade marks of Helsinn Healthcare SA, Switzerland. Distributed under license of Helsinn Healthcare SA, Switzerland.

® FOLOTYN is a registered trade mark of Allos Therapeutics Inc and is used by Mundipharma Pty Limited as Authorized User.